Arkansas

Start Pallas's online intake — it takes a few minutes and covers your health history, goals, and current medications. Because Arkansas does not allow a provider-patient relationship to be established by an online questionnaire alone, an Arkansas-licensed clinician completes a live video visit before any prescription is issued. If a GLP-1 is clinically appropriate, your clinician prescribes it, and a US-licensed pharmacy ships your medication to any Arkansas address in 2–3 business days.

The process is the same as for semaglutide — complete Pallas's online intake, then meet with an Arkansas-licensed clinician over live video, required before any prescription in Arkansas. If appropriate, your clinician can prescribe either compounded tirzepatide, prepared per-patient by a US-licensed §503A pharmacy based on a documented clinical rationale, or an FDA-approved brand-name option like Zepbound^® or Mounjaro^®, through the same intake. These are distinct products with different regulatory status; your clinician will explain which fits you.

Yes — compounded semaglutide is available to eligible Arkansas residents through licensed telehealth. It is prepared per-patient by US-licensed §503A compounding pharmacies for an individual patient from a valid, patient-specific prescription — a distinct legal category from Wegovy^® or Ozempic^®, not itself an FDA-approved drug — and an Arkansas-licensed clinician must prescribe it based on a documented, patient-specific clinical rationale. Pallas serves Arkansas with free shipping. FDA-approved brand-name options like Wegovy^® and Zepbound^® are also available through the same intake.

Yes, within the limits of Arkansas's nurse practitioner scope of practice. Arkansas is a reduced-practice state — a nurse practitioner needs a current collaborative practice agreement with a physician on file with the Arkansas State Board of Nursing, unless the NP holds a separate board certificate for independent practice after 6,240 qualifying practice hours (Ark. Code Ann. §17-87-310). Physicians licensed in Arkansas can prescribe independently. Every Pallas prescription for an Arkansas patient is written by an Arkansas-licensed physician or, where applicable, a nurse practitioner practicing within these requirements.

Several licensed telehealth platforms serve Arkansas residents seeking compounded semaglutide. Before choosing one, verify that its clinicians are licensed in Arkansas, that it dispenses through US-licensed §503A compounding pharmacies, and that it carries LegitScript certification — checkable in LegitScript's public database. Pallas Health serves Arkansas residents, works only with US-licensed pharmacies.

Yes — Arkansas does not let a provider-patient relationship be established by an online questionnaire or a patient-generated medical history alone, so your Arkansas-licensed Pallas provider meets with you over live video to evaluate eligibility and, if appropriate, writes a prescription that ships directly to your address. After that first visit, ongoing care — check-ins, dose adjustments, and refill questions — is handled asynchronously by secure message. You never need to visit a physical office.

Pallas is a cash-pay telehealth service — there is no insurance to bill, and that includes Medicaid, which covers GLP-1s in Arkansas for type 2 diabetes with prior authorization, only in limited cases for weight management, and never for compounded GLP-1s, though none of that affects your price with Pallas. Your Pallas Membership covers your clinician's review, ongoing check-ins, and care-team messaging; the medication is billed separately and ships free to your Arkansas address, only when a clinician prescribes it. You see your full price during intake before you pay anything — no surprise renewal markups. The price is the same whether you are in Little Rock, Fayetteville, or a rural Arkansas ZIP code.

Eligibility is always decided by an Arkansas-licensed clinician after your intake and video visit, never by an automated quiz. In general, GLP-1 medications for weight management are considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher together with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea. Your clinician also reviews your medical history and current medications to confirm a GLP-1 is appropriate and safe for you, and will tell you if it is not.

Brand-name medications — Wegovy^® and Ozempic^® (semaglutide) and Zepbound^® and Mounjaro^® (tirzepatide) — are FDA-approved products from their manufacturers, offered cash-pay. Compounded semaglutide and tirzepatide are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy, when a clinician documents a patient-specific clinical need. While these pharmacies are highly regulated, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Which option fits you is a clinical decision you make with your Arkansas-licensed provider.

Yes, many patients transfer their care to Pallas. During your video visit you tell your clinician which medication and dose you take now and how you have tolerated it. Your Arkansas-licensed provider reviews that history and, if appropriate, continues you at a comparable dose or adjusts your titration plan. Do not stop or change a prescription on your own — let your clinician guide any transition.

Most patients use a once-weekly injection with a very fine needle, but a compounded oral semaglutide tablet is available for people who would rather not inject. Both are prescribed only after a clinician confirms they are appropriate for you, and your provider can help you weigh which form fits your routine and goals.

The most common side effects are gastrointestinal — nausea, constipation, diarrhea, or reflux — and they are usually mildest when the dose is raised slowly, which is why clinicians titrate up gradually. GLP-1s are not right for everyone; they are avoided in people with a personal or family history of medullary thyroid carcinoma or MEN2, and during pregnancy. Your Pallas clinician screens for these before prescribing and stays available to help you manage any side effects.

You complete a detailed online intake sharing your health history, goals, and current medications, then meet with a clinician licensed by the Arkansas State Medical Board over live video — Arkansas does not allow an online questionnaire alone to establish your provider relationship, so this real-time visit is what establishes your care. After that initial visit, most ongoing care, including check-ins, dose adjustments, and refill questions, can be handled asynchronously by secure message. If a GLP-1 is appropriate, your prescription goes to a licensed pharmacy that ships to any Arkansas address, usually within 2–3 business days — Little Rock, Fayetteville, and Jonesboro typically ship fastest, with rural addresses sometimes taking an extra day.

Pallas care is ongoing, not a one-time script. Your plan renews on a regular cadence so your medication arrives before you run out, and your clinician schedules check-ins to monitor your response, adjust your dose, and manage side effects. You can message your care team from the Pallas app or your patient portal, and change your plan or cancel anytime from the portal — no phone calls or retention hoops.

Many patients take a GLP-1 alongside metformin, statins, or blood pressure medication, and these are commonly used together under a clinician's supervision. Your Arkansas-licensed provider reviews your complete medication list during intake, including insulin or sulfonylureas, which can raise the risk of low blood sugar when combined with a GLP-1 and may call for a dose adjustment. List every medication and supplement you take so your clinician can confirm a GLP-1 is safe to add.

After your Arkansas-licensed provider approves your prescription, most patients start at the lowest dose, taken once weekly, with the dose increased gradually over the following weeks to reduce nausea and other GI side effects. Your care team checks in during this period to see how you're tolerating the medication and to answer questions by secure message. If you're not tolerating the starting dose well, your clinician can adjust your titration schedule before your next shipment ships to your Arkansas address.

Compounded semaglutide injection through Pallas is $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Arkansas address, only if a clinician prescribes it, and you are refunded in full if a clinician decides treatment isn't right for you.

Compounded tirzepatide injection through Pallas is $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Arkansas address, only if a clinician prescribes it, and you are refunded in full if a clinician decides treatment isn't right for you.

Yes. FDA-approved Wegovy^® (pen or pill), Zepbound^® and Foundayo^™ for chronic weight management — plus Ozempic^® and Mounjaro^® for type 2 diabetes — are available to Arkansas patients cash-pay: the daily Wegovy^® pill and Foundayo^™ are $299 for your first month, then $499 every 4 weeks, and the weekly pens start at $1,069/mo; insurance is not billed. Whether a brand-name or compounded medication is appropriate for you is determined by a clinician licensed in Arkansas during intake.

Coverage of GLP-1 medications for weight loss through Medicaid is limited. Arkansas Medicaid covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service — we do not bill Medicaid or private insurance. Pricing is flat and disclosed up front; the cost questions on this page carry current plan terms.

You have two cash-pay paths in Arkansas, and neither requires insurance. One: stay on FDA-approved Wegovy^® or Zepbound^® at flat cash-pay pricing from $1,069/mo. Two: if a clinician licensed in Arkansas determines it is clinically appropriate for you, a compounded semaglutide plan ($139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime.) or compounded tirzepatide plan ($179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime.), prepared per-patient by a US-licensed pharmacy under FDCA §503A. There is no gap in care: start the online intake, tell your clinician what you take now and your current dose, and they factor that history into your treatment plan and starting dose. Our guide to switching GLP-1 telehealth providers on the Pallas blog covers records, timing, and what to expect.

That is a decision you make with your clinician. Semaglutide activates the GLP-1 receptor; tirzepatide activates both the GLP-1 and GIP receptors. In the SURMOUNT-5 head-to-head trial of the FDA-approved products, Zepbound^® (tirzepatide 10 mg or 15 mg weekly) produced greater average weight loss than Wegovy^® (semaglutide 1.7 mg or 2.4 mg weekly) — 20.2% versus 13.7% of body weight over 72 weeks. Wegovy^®'s maximum dose is now 7.2 mg weekly, which was not studied in SURMOUNT-5; in the separate STEP UP trial it reached 18.7% average weight loss over 72 weeks. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary. Semaglutide plans cost less and semaglutide has the longer post-market record; a clinician licensed in Arkansas weighs your history, goals, and budget to recommend a starting point.

It depends on what you are comparing. Pallas is a cash-pay telehealth service that serves every ZIP code in Arkansas with one all-in plan price for compounded semaglutide: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. There is no separate membership fee, and nothing is charged until a clinician prescribes. Arkansas requires one live video visit, which is included. Before paying any service, check whether the quoted price includes the medication or is a membership billed on top of it, whether the company is LegitScript-certified, and whether you are charged before a clinician has prescribed. The comparison table on this page quotes other services' published prices as of September 24, 2026.